Deleterious Role of Th9 Cells in Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease of unknown etiology. Immune disorders play an important role in IPF pathogenesis. Here, we show that Th9 cells differentiate and activate in the lung tissue of patients with IPF and bleomycin (BLM)-induced lung fibrosis mice...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kui Miao Deng, Xiang Sheng Yang, Qun Luo, Yi Xin She, Qing Yang Yu, Xiao Xiao Tang
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/6209b4965f4b465b998879e29900aee2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6209b4965f4b465b998879e29900aee2
record_format dspace
spelling oai:doaj.org-article:6209b4965f4b465b998879e29900aee22021-11-25T17:12:56ZDeleterious Role of Th9 Cells in Pulmonary Fibrosis10.3390/cells101132092073-4409https://doaj.org/article/6209b4965f4b465b998879e29900aee22021-11-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/3209https://doaj.org/toc/2073-4409Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease of unknown etiology. Immune disorders play an important role in IPF pathogenesis. Here, we show that Th9 cells differentiate and activate in the lung tissue of patients with IPF and bleomycin (BLM)-induced lung fibrosis mice. Moreover, we found that Th9 cells promote pulmonary fibrosis in two ways. On the one hand, Th9 cells promote fibroblast differentiation, activation, and collagen secretion by secreting IL-9. On the other hand, they promote differentiation of Th0 cells into Th2 cells by secreting IL-4. Th9 cells and Th2 cells can promote each other, accelerating the Th1/Th2 imbalance and eventually forming a positive feedback of pulmonary fibrosis. In addition, we found that neutralizing IL-9 in both preventive and therapeutic settings ameliorates bleomycin-induced pulmonary fibrosis. Furthermore, we identified several critical signaling pathways involved in the effect of neutralizing IL-9 on pulmonary fibrosis by proteomics study. From an immunological perspective, we elucidated the novel role and underlying mechanism of Th9 cells in pulmonary fibrosis. Our study suggested that Th9-based immunotherapy may be employed as a treatment strategy for IPF.Kui Miao DengXiang Sheng YangQun LuoYi Xin SheQing Yang YuXiao Xiao TangMDPI AGarticleidiopathic pulmonary fibrosisTh9 cellsTh2 cellsinterleukin-9Biology (General)QH301-705.5ENCells, Vol 10, Iss 3209, p 3209 (2021)
institution DOAJ
collection DOAJ
language EN
topic idiopathic pulmonary fibrosis
Th9 cells
Th2 cells
interleukin-9
Biology (General)
QH301-705.5
spellingShingle idiopathic pulmonary fibrosis
Th9 cells
Th2 cells
interleukin-9
Biology (General)
QH301-705.5
Kui Miao Deng
Xiang Sheng Yang
Qun Luo
Yi Xin She
Qing Yang Yu
Xiao Xiao Tang
Deleterious Role of Th9 Cells in Pulmonary Fibrosis
description Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease of unknown etiology. Immune disorders play an important role in IPF pathogenesis. Here, we show that Th9 cells differentiate and activate in the lung tissue of patients with IPF and bleomycin (BLM)-induced lung fibrosis mice. Moreover, we found that Th9 cells promote pulmonary fibrosis in two ways. On the one hand, Th9 cells promote fibroblast differentiation, activation, and collagen secretion by secreting IL-9. On the other hand, they promote differentiation of Th0 cells into Th2 cells by secreting IL-4. Th9 cells and Th2 cells can promote each other, accelerating the Th1/Th2 imbalance and eventually forming a positive feedback of pulmonary fibrosis. In addition, we found that neutralizing IL-9 in both preventive and therapeutic settings ameliorates bleomycin-induced pulmonary fibrosis. Furthermore, we identified several critical signaling pathways involved in the effect of neutralizing IL-9 on pulmonary fibrosis by proteomics study. From an immunological perspective, we elucidated the novel role and underlying mechanism of Th9 cells in pulmonary fibrosis. Our study suggested that Th9-based immunotherapy may be employed as a treatment strategy for IPF.
format article
author Kui Miao Deng
Xiang Sheng Yang
Qun Luo
Yi Xin She
Qing Yang Yu
Xiao Xiao Tang
author_facet Kui Miao Deng
Xiang Sheng Yang
Qun Luo
Yi Xin She
Qing Yang Yu
Xiao Xiao Tang
author_sort Kui Miao Deng
title Deleterious Role of Th9 Cells in Pulmonary Fibrosis
title_short Deleterious Role of Th9 Cells in Pulmonary Fibrosis
title_full Deleterious Role of Th9 Cells in Pulmonary Fibrosis
title_fullStr Deleterious Role of Th9 Cells in Pulmonary Fibrosis
title_full_unstemmed Deleterious Role of Th9 Cells in Pulmonary Fibrosis
title_sort deleterious role of th9 cells in pulmonary fibrosis
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/6209b4965f4b465b998879e29900aee2
work_keys_str_mv AT kuimiaodeng deleteriousroleofth9cellsinpulmonaryfibrosis
AT xiangshengyang deleteriousroleofth9cellsinpulmonaryfibrosis
AT qunluo deleteriousroleofth9cellsinpulmonaryfibrosis
AT yixinshe deleteriousroleofth9cellsinpulmonaryfibrosis
AT qingyangyu deleteriousroleofth9cellsinpulmonaryfibrosis
AT xiaoxiaotang deleteriousroleofth9cellsinpulmonaryfibrosis
_version_ 1718412591505604608